682 related articles for article (PubMed ID: 27181776)
21. [Peculiarity of infantile cystinosis in Tunisian children].
Jellouli M; Ben Turkia H; Abidi K; Hammi Y; Gargah T
Pan Afr Med J; 2015; 22():348. PubMed ID: 26985266
[TBL] [Abstract][Full Text] [Related]
22. Nephropathic cystinosis: late complications of a multisystemic disease.
Nesterova G; Gahl W
Pediatr Nephrol; 2008 Jun; 23(6):863-78. PubMed ID: 18008091
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of starting oral cysteamine treatment in the first 2 months of life on glomerular and tubular kidney function in infantile nephropathic cystinosis.
Hohenfellner K; Nießl C; Haffner D; Oh J; Okorn C; Palm K; Schlingmann KP; Wygoda S; Gahl WA
Mol Genet Metab; 2022 Aug; 136(4):282-288. PubMed ID: 35843134
[TBL] [Abstract][Full Text] [Related]
24. Nephropathic cystinosis in Poland: a 40-year retrospective study.
Sikora P; Grenda R; Kowalczyk M; Kieć-Wilk B; Bieniaś B; Rubik J; Szymczak M; Nosek H; Surowiec P; Marquardt T; Beck BB; Zaniew M
Pol Arch Intern Med; 2022 Nov; 132(11):. PubMed ID: 35997069
[TBL] [Abstract][Full Text] [Related]
25. Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.
Machuca-Gayet I; Quinaux T; Bertholet-Thomas A; Gaillard S; Claramunt-Taberner D; Acquaviva-Bourdain C; Bacchetta J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32354056
[TBL] [Abstract][Full Text] [Related]
26. [From gene to disease: cystinosis].
Levtchenko EN; Wilmer M; de Graaf-Hess AC; van den Heuvel LP; Blom H; Monnens LA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):476-8. PubMed ID: 15042893
[TBL] [Abstract][Full Text] [Related]
27. [Cystinosis].
Watanabe H; Kamoshita S
Nihon Rinsho; 1992 Jul; 50(7):1593-8. PubMed ID: 1404889
[TBL] [Abstract][Full Text] [Related]
28. [Improved prognosis of cystinosis achieved by treatment with cysteamine and by kidney transplantation].
Oczachowska-Kulik AE; Lund AM; Skovby F; Pedersen EB
Ugeskr Laeger; 2011 Aug; 173(33):1958-62. PubMed ID: 21849135
[TBL] [Abstract][Full Text] [Related]
29. Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis: First human report.
Elmonem MA; Veys K; Oliveira Arcolino F; Van Dyck M; Benedetti MC; Diomedi-Camassei F; De Hertogh G; van den Heuvel LP; Renard M; Levtchenko E
Am J Transplant; 2018 Nov; 18(11):2823-2828. PubMed ID: 30030899
[TBL] [Abstract][Full Text] [Related]
30. Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells.
Rega LR; Polishchuk E; Montefusco S; Napolitano G; Tozzi G; Zhang J; Bellomo F; Taranta A; Pastore A; Polishchuk R; Piemonte F; Medina DL; Catz SD; Ballabio A; Emma F
Kidney Int; 2016 Apr; 89(4):862-73. PubMed ID: 26994576
[TBL] [Abstract][Full Text] [Related]
31. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
Veys K; Zadora W; Hohenfellner K; Bockenhauer D; Janssen MCH; Niaudet P; Servais A; Topaloglu R; Besouw M; Novo R; Haffner D; Kanzelmeyer N; Pape L; Wühl E; Harms E; Awan A; Sikora P; Ariceta G; van den Heuvel B; Levtchenko E
J Inherit Metab Dis; 2023 Jan; 46(1):43-54. PubMed ID: 36117148
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of nephropathic cystinosis with cysteamine.
Kleta R; Gahl WA
Expert Opin Pharmacother; 2004 Nov; 5(11):2255-62. PubMed ID: 15500372
[TBL] [Abstract][Full Text] [Related]
33. Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction.
Elmonem MA; Khalil R; Khodaparast L; Khodaparast L; Arcolino FO; Morgan J; Pastore A; Tylzanowski P; Ny A; Lowe M; de Witte PA; Baelde HJ; van den Heuvel LP; Levtchenko E
Sci Rep; 2017 Feb; 7():42583. PubMed ID: 28198397
[TBL] [Abstract][Full Text] [Related]
34. Cystinosin is a Component of the Vacuolar H+-ATPase-Ragulator-Rag Complex Controlling Mammalian Target of Rapamycin Complex 1 Signaling.
Andrzejewska Z; Nevo N; Thomas L; Chhuon C; Bailleux A; Chauvet V; Courtoy PJ; Chol M; Guerrera IC; Antignac C
J Am Soc Nephrol; 2016 Jun; 27(6):1678-88. PubMed ID: 26449607
[TBL] [Abstract][Full Text] [Related]
35. Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy.
Sonies BC; Almajid P; Kleta R; Bernardini I; Gahl WA
Medicine (Baltimore); 2005 May; 84(3):137-146. PubMed ID: 15879904
[TBL] [Abstract][Full Text] [Related]
36. Infantile cystinosis: From dialysis to renal transplantation.
Jellouli M; Ferjani M; Abidi K; Zarrouk C; Abdelmoula J; Gargah T
Saudi J Kidney Dis Transpl; 2017; 28(5):1180-1183. PubMed ID: 28937083
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
Higashi S; Matsunoshita N; Otani M; Tokuhiro E; Nozu K; Ito S
BMC Nephrol; 2017 Sep; 18(1):300. PubMed ID: 28950840
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis.
Harrison F; Yeagy BA; Rocca CJ; Kohn DB; Salomon DR; Cherqui S
Mol Ther; 2013 Feb; 21(2):433-44. PubMed ID: 23089735
[TBL] [Abstract][Full Text] [Related]
39. Natural history of adolescent-onset cystinosis.
Midgley JP; El-Kares R; Mathieu F; Goodyer P
Pediatr Nephrol; 2011 Aug; 26(8):1335-7. PubMed ID: 21553323
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
